Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hei Ton Chan
Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Older, Vulnerable Patients With Relapsed/Refractory Large B-Cell Lymphoma
Haematologica
Hematology
Related publications
Anti-Cd19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Frontiers in Oncology
Cancer Research
Oncology
Chimeric Antigen Receptor T-Cells (Car-T) for Refractory and Relapsed Burkitt's Lymphoma: Early Response in Pediatric Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma
American Journal of Hematology
Hematology
Advancing Chimeric Antigen Receptor T Cell Therapy With CRISPR/Cas9
Protein & Cell
Biochemistry
Biotechnology
Drug Discovery
Cell Biology
Medicine
Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
International Journal of Hematology
Hematology
Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
